Researchers at Stanford and the Chan Zuckerberg Biohub have developed a transcriptomic characterization of human endometrium and identified specific gene signatures for use in evaluating endometrial samples for one or more menstrual cycle events.
Researchers at Stanford have developed the SNAIL-RCA method for inexpensive and efficient multiplexed detection of single RNA molecules in single cells.
Researchers at Stanford and the Chan Zuckerberg Biohub have developed methods for independent tuning of aptamer switching binding affinities and kinetics.
Engineers at Stanford have invented a smart toilet platform that will autonomously monitor excreted waste from humans. We describe easily deployable hardware and software for the long-term analysis of a user's excreta through data collection and models of human health.
Researchers at Stanford have developed a non-invasive method, based on the identification of novel immune signatures in the blood, for diagnosing Crohn's disease (CD) or ulcerative colitis (UC) in patients with inflammatory bowel disease (IBD).
Stanford researchers at the Genome Technology Center have developed a simple, reliable, and accurate method for obtaining sequencing information for multiple sites within target nucleic acid.
Researchers at Stanford have developed a new therapeutic to promote survival of retinal ganglion cells (RGCs) and optic nerve regeneration after traumatic injury or optic neuropathies.
Running chemotherapeutic drug screens on tumor biopsies ex vivo has the potential to increase patient survival by personally matching them to the drug which is the most effective against their particular tumor.
Researchers at Stanford have developed new fluorescent sensors to detect and monitor gastrointestinal (GI) permeability. GI permeability can be correlated with the prognosis of GI disease, thus earlier detection may lead to better patient outcomes.
High-grade serous ovarian cancer (HG-SOC) is the most lethal gynecologic malignancy, in large part because most patients present with late-stage disease and receive the same therapeutic regimen despite significant heterogeneity in disease and clinical response.
Stanford researchers at the Rao Lab have developed apoptosis imaging probes with an improved new molecular structure enabling high sensitivity and stability with better performance in vivo.
Researchers at Stanford have developed the paperfuge- an ultra-low cost (20 cents), light weight (2g) field portable centrifuge (125,000 rpm; 30,000 g RCF) made out of paper that runs on human power.
Stanford researchers have developed a PCR-based method that detects disease-relevant, isotype-specific antibodies and can be used to diagnose allergy. Allergy is a prevalent immune hypersensitivity disease that affects more than 20% of the US population.